Methadone
NIDA-08045-6
Phase 3 small_molecule terminated
Quick answer
Methadone for Opioid-Related Disorders is a Phase 3 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Opioid-Related Disorders
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated